MAINZ — Pfizer Japan Inc. and BioNTech SE (Nasdaq: BNTX, “BioNTech”) announced conclusion of an agreement between the Japanese government and Pfizer Japan Inc. to supply an additional 10 million doses of the Omicron XBB.1.5-adapted COVID-19 vaccine (COMIRNATY Omicron XBB.1.5) for the special vaccination program in Japan which started this autumn. The vaccine doses to be supplied based on this agreement will be …